Most Read News

On 27 September 2022

Company reported standalone production of Rolled Products (Flat) at 12.01 lakh tonnes.

Since more than 85% of the company's inventory is made up of business hotels, the growing popularity of corporate travel will be extremely beneficial for it, according to the company's annual report

Zydus was among the first ANDA applicants to file a substantially complete ANDA with a paragraph IV certification for Cariprazine Capsules.

The UK economy expanded in July underpinned by the rebound in the service sector, data from the Office for National Statistics showed. Gross domestic product grew 0.2 percent in July, in contrast to a fall of 0.6 percent in June. Monthly GDP is estimated to be 1.1 percent above its pre-coronavirus levels. GDP was flat in the three months to July compared with the previous […]

Zydus Lifesciences rose 1.51% to Rs 380 after Cadila Healthcare, U.S. subsidiary of the company has received final approval from the USFDA to market Cariprazine capsules.

For REITs - while FY23 distribution is largely expected to be flat YoY — analysts at IIFL Capital Services see meaningful pickup in occupancy levels over the next 3-4 quarters. They build 5.2-6.2% pre-tax yield for FY23, and upgrade Embassy Office Parks REIT (EOP) to Buy post recent weakness; retain Add for Mindspace Business Parks REIT (MREIT) and Reduce for Brookfield India Real Estate Trust REIT (BIRET).

On 29 September 2022

On 26 September 2022

On 27 September 2022